United States · FDA National Drug Code directory
LORAZEPAM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61919-062_47e14ab4-5eb4-67c7-e063-6394a90a1e4b
- Product NDC
- 61919-062
- Form
- TABLET
- Composition / generic term
- LORAZEPAM
- Labeler
- DIRECT RX
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170210
- Source listing expiry
- 20271231
Source-listed ingredients
- LORAZEPAM — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET in 1 BOTTLE (61919-062-02) · 61919-062-02
- 60 TABLET in 1 BOTTLE (61919-062-60) · 61919-062-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →